SEOUL, South Korea, Feb. 4, 2026 -- Yuyu Pharma announced today a strategic investment in James & Ella, the United Kingdom's fastest-growing freeze-dried pet nutrition company. Founded by entrepreneur James Middleton, James & Ella has rapidly established itself as the leader of the UK freeze-dried category, with nationwide distribution through Sainsbury's, Waitrose, Ocado, and Amazon UK, supported by a strongly expanding direct-to-consumer subscription channel. This investment reflects Yuyu Pharma's expanding global focus on premium pet wellness. Freeze-dr
HONG KONG, Feb. 4, 2026 -- PhotonPay, a leading global digital financial infrastructure platform, today announced a strategic partnership with Stripe, a financial infrastructure platform for businesses. By integrating Stripe's robust infrastructure, PhotonPay is elevating its online acquiring capabilities, ensuring merchants can scale seamlessly across multiple regions with unmatched efficiency and reliability. Through this partnership, PhotonPay will deepen the integration of Stripe's payment infrastructure into its platform, strengthening the breadth and resilience of its onl
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Feb. 4, 2026 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Veradermics (NYSE: MANE), a hair loss biotech company, set for NYSE trading debut Ashley Mastronardi delivers the pre-market update on February 4th Stocks are moving higher early Wednesday as traders rotate into economically sensitive sectors. Small-cap stocks have b
ONTARIO, Calif., Feb. 4, 2026 -- Nature's Miracle Holding Inc. (OTCQB: NMHI) ("Nature's Miracle" or the "Company"), a leader in controlled environment agricultural technology, today announced it has entered into a formal Settlement Agreement and Mutual Release with Megaphoton Inc. The agreement effectively resolves all outstanding legal disputes and trade payables between the two parties. Under the terms of the agreement, Nature's Miracle will issue 15 million shares of common stock (approximately 13% of the Company's outstanding shares) to Meg
ONTARIO, Calif., Feb. 4, 2026 -- Nature's Miracle Holding Inc. (OTCQB: NMHI) today announced the appointment of Dr. Jinlong "Frank" Du as President of the Company's Agricultural Business. Dr. Du is a globally recognized entrepreneur and technology leader in indoor growing and controlled environment agriculture ("CEA"), with more than 20 years of experience in modern CEA and advanced facility agriculture. He is the founder and former Chief Executive Officer of Megaphoton, Inc., a technology company specializing in advanced horticultural lighting
HONG KONG, Feb. 4, 2026 -- CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS), today announced that its Board of Directors has approved a share repurchase program. Under the program, the Company is authorized to repurchase up to 1,000,000 of its outstanding common shares in the open market at prevailing market prices, specifically when the Company's share price is below US$2.00 per share. The repurchase program is scheduled to commence on February 5, 2026, and will conclude on November 4, 2026. By implementing this program, the Board aims to reinforce the C
- Lezhin Entertainment Targets Global Short-Form Drama Market with Original IP- Renowned Korean Directors Lee Joon-ik and Lee Byung-hun Join the Platform's Debut Lineup- Simultaneous Launch in Korea, the U.S., and Japan on February 4 SEOUL, South Korea, Feb. 4, 2026 -- Lezhin Entertainment, a leading pioneer of the K-webtoon industry, announced today the official launch of Lezhin Snack, a new global short-form drama platform, marking a major step in the company's strategy to build a comprehensive global IP value chain. Responding to a Fundamental Shift in Content Cons
[ 메디채널 김갑성 기자 ] Landmark Australian study opens new possibilities for children with aggressive brain tumors and signals opportunity for Canada and USA. CALGARY, AB and BRISBANE, Australia , Feb. 5, 2026 -- Providence Therapeutics, a Canadian clinical-stage mRNA biotechnology company, is supporting a world-first clinical trial evaluating personalized mRNA cancer vaccines for children with advanced and treatment-resistant brain tumors. The PaedNEO-VAX trial, funded by Providence Therapeutics, in combination with the Australian Government and a host of philanthropic donors, is th
알울라, 사우디아라비아, 2026년 2월 4일 -- 사우디아라비아 왕국이 사우디 재무부(Ministry of Finance), 국제통화기금(International Monetary Fund)과의 제휴로 2026년 2월 8~9일 알울라 주(AlUla Governorate)에서 개최 예정인 제2차 알울라 신흥시장 경제 컨퍼런스(AlUla Conference for Emerging Market Economies, ACEME) 준비에 한창이다. 이번 행사에는 각국의 재무장관과 중앙은행 총재, 정책 결정자들을 비롯해 국제 금융기구 수장과 세계 각국의 경제 전문가들이 참석한다. 이번 컨퍼런스는 세계 경제가 빠르게 변화하는 가운데 열리는 것이다. 이 같은 환경은 신흥시장 경제국들이 회복탄력성을 강화하고 새로운 기회를 포착해 지속 가능한 성장을 확보하고 생활 수준을 개선할 것을 요구하고 있으며, 이는 궁극적으로 글로벌 경제 안정성에도 긍정적인 영향을 미칠 것으로 전망된다. ACEME는 사우디 재무부와 국제통화기금 간의 중요한 전략적 파트너십을 보여주는 동시에, 국제 경제 대화를 지원하고 국제 협력을 강화하는 데 있어
[ 메디채널 김갑성 기자 ] The National Comprehensive Cancer Network pledges to update robust information resources for cancer patients and caregivers on an annual basis in both English and Spanish. PLYMOUTH MEETING, Pa., Feb. 4, 2026 -- [ 메디채널 김갑성 기자 ] The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers based in the United States—and the NCCN Foundation® is honoring World Cancer Day with an announcement about more frequent updates to its free educational resources intended to empower shared decision-making. World Cancer Day is a